VLT-001

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameVLT-001
Drug Alias Namemyotonic dystrophy therapy (Neuron Bio/VLT Biopharma)myotonic dystrophy therapy (Neuron Biopharma/VLT Biopharma)myotonic dystrophy therapy (Neuron Biopharma/Valentia Biopharma)VLT-001ABP-1
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuron Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVlt BiopharmaNeuron Bio
Active IndicationsN/A
Inactive IndicationsMyotonic Dystrophy

Other Information

ATC CodeN/A
Related LinksN/A